Anika Therapeutics (ANIK) Work In Process (2011 - 2018)

Anika Therapeutics (ANIK) has 8 years of Work In Process data on file, last reported at $5.9 million in Q3 2018.

• Work In Process for Q3 2018 came in at $5.9 million, down 9.38% year-over-year; the trailing twelve-month figure through Sep 2018 was $5.9 million (down 9.38% YoY), and the FY2017 annual result was $6.1 million, up 9.05% from the prior year.
• Work In Process fell to $5.9 million in Q3 2018 per ANIK's latest filing, from $6.3 million in the prior quarter.
• Over five years, Work In Process peaked at $6.6 million in Q3 2017 and troughed at $2.2 million in Q2 2014.
• A 5-year average of $4.8 million and a median of $5.6 million in 2016 frame the typical range for Work In Process.
• The sharpest annual moves came in 2016 and 2018: Work In Process surged 94.43% in 2016, then fell 9.38% in 2018.
• A 5-year view of Work In Process shows it stood at $3.0 million in 2014, then soared by 85.99% to $5.7 million in 2015, then retreated by 1.71% to $5.6 million in 2016, then increased by 9.05% to $6.1 million in 2017, then dropped by 1.88% to $5.9 million in 2018.
• Business Quant data shows ANIK's Work In Process at $5.9 million in Q3 2018, $6.3 million in Q2 2018, and $5.9 million in Q1 2018.